Song et al. revealed that USP10 deletion is associated with advanced tumor-related phenotypes, and that co-deletion of USP10 and p14ARF yields poor outcomes in small intestinal adenocarcinoma, indicating that USP10 and p14ARF may be involved in small intestinal adenocarcinoma (69). Here, USP10 is linked to neoplasm.